Physalis angulata induced G2/M phase arrest in human breast cancer cells

Food and Chemical Toxicology

Volumn 44, Issue 7, 2006, Pages 974-983

  Hsieh, Wen Tsong ^a   Huang, Kuan Yuh ^a   Lin, Hui Yi ^a   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Flow cytometric assay; G2 M phase arrest; Human breast cancer MDA MB 231 cells; Physalis angulata

Indexed keywords

CHECKPOINT KINASE 2; CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE; PHYSALIS ANGULATA EXTRACT; PLANT EXTRACT; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL ACTIVATION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEDICINAL PLANT; PHOSPHORYLATION; PHYSALIS; PHYSALIS ANGULATA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN A; CYCLIN B; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLOW CYTOMETRY; G2 PHASE; HUMANS; NEOPLASM PROTEINS; PHYSALIS; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

PHYSALIS ANGULATA;

EID: 33744934200     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.11.013     Document Type: Article

References (44)

1. Ahn J.Y., Schwarz J.K., Piwnica-Worms H., and Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60 (2000) 5934-5936
2. Barboule N., Lafon C., Chadebech P., Vidal S., and Valette A. Involvement of p21 in the PKC-induced regulation of G2/M cell cycle transition. FEBS Lett. 444 (1999) 32-37
3. Barkett M., Xue D., Horvitz H.R., and Gilmore T.D. Phosphorylation of IkBα inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272 (1997) 29419-29422
4. Chaturvedi P., Eng W.K., Zhu Y., Mattern M.R., Mishra R., Hurle M.R., Zhang X., Annan R.S., Lu Q., Faucette L.F., Scott G.F., Li X., Carr S.A., Johnson R.K., Winkler J.D., and Zhou B.B.S. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18 (1999) 4047-4054
5. Chiang H.C., Jaw S.M., and Chen P.M. Inhibitory effects of physalin B and physalin F on various human leukemia cells in vitro. Anticancer Res. 12 4 (1992) 1155-1162
6. Chiang H.C., Jaw S.M., Chen C.F., and Kan W.S. Antitumor agent, physalin F from PAL. Anticancer Res. 12 3 (1992) 837-843
7. Desagher S., and Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell. Biol. 10 (2000) 369-377
8. Donaldson K.L., Goolsby G.L., Kiener P.A., and Wahl A.F. Activation of p34Cdc2 coincident with taxol-induced apoptosis. Cell Growth Diff. 5 (1994) 1041-1050
9. EI-Deiry J.W.S., Harper W., Connor P.M.O., Velculescu V.E., Canman C.E., Jackman A., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., and Vogelsein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 (1994) 1169-1174
10. Flatt P.M., and Pietenpol J.A. Mechanism of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery. Drug Metab. Rev. 32 (2000) 283-305
11. Gao Y., Ma Y., Li M., Cheng T., Li S.W., Zhang J., and Xia N.S. Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg. World J. Gastroenterol. 9 5 (2003) 996-1002
12. Gross A., McDonnell J.M., and Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13 (1999) 1899-1911
13. Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., and Jackson S.P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82 (1995) 849-856
14. Hollman P.C., and Katan M.B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 51 (1996) 305-310
15. Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83 (1995) 1-4
16. Ismail N., and Alam M. A novel cytotoxic flavonoid glycoside from Physalis angulata. Fitoterapia 72 6 (2001) 676-679
17. Jaroszeski M.J., and Heller R. Flow Cytometry Protocols (1998), Humanan Press pp. 77-80
18. Juang J.K., Huang H.W., Chen C.M., and Liu H.J. A new compound, withangulatin A, promotes type II DNA topoisomerase-mediated DNA damage. Biochem. Biophys. Res. Commun. 159 3 (1989) 1128-1134
19. Kaufmann S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous breast cancer cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49 (1989) 5870-5878
20. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
21. Kuo P.L., Lin T.C., and Lin C.C. The antiproliferative activity of PA is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 71 (2002) 1879-1892
22. Leach S.D., Scatena C.D., Keefer C.J., Goodman H.A., Song S.Y., Yang L., and Pietenpol J.A. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res. 58 (1998) 3231-3236
23. Lee H.Z., Hsu S.L., Liu M.C., and Wu C.H. Effects and mechanisms of PA on cell death in human lung squamous cell carcinoma. Eur. J. Pharmacol. 431 (2001) 287-295
24. Lin Y.S., Chiang H.C., Kan W.S., Hone E., Shih S.J., and Won M.H. Immunomodulatory activity of various fractions derived from Physalis angulata L extract. Am. J. Chin. Med. 20 3-4 (1992) 233-243
25. Ling Y.H., Priebe W., and Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 53 (1993) 1845-1852
26. Makino B., Ohya J., Yamamura H., Araki S., Butsugan Y., and Kawai M. Cytotoxic activity of physalins possessing modified skeletal structures against HeLa cells. Pharmazie 58 1 (2003) 70-71
27. McIntyre B.S., and Sylvester P.W. Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regulation. Cell Prolif. 31 (1998) 35-46
28. Nakamura Y. ATM: the p53 booster. Nat. Med. 4 (1998) 1231-1232
29. Niculescu III A.B., Chen X., Smeets M., Hengst L., Prives C., and Reed S.I. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transition: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18 (1998) 629-643
30. Ormerod M.G. Flow Cytometry: A Practical Approach (1990), Oxford University Press pp. 69-81
31. Panaro N.J., Popescu N.C., Harris S.R., and Thorgeirsson U.P. Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells. Br. J. Cancer 80 (1999) 1905-1911
32. Pietro R.C., Kashima S., Sato D.N., Januario A.H., and Franca S.C. In vitro antimycobacterial activities of Physalis angulata L. Phytomedicine 7 4 (2000) 335-338
33. Reuther J.Y., and Baldwin Jr. A.S. Apoptosis promotes a caspase-induced amino-terminal truncation of IkBα, that functions as a stable inhibitor of NF-kB. J. Biol. Chem. 274 (1999) 20664-20670
34. Rivard N., Boucher M.-J., Asselin C., and L'Allemain G. MAP kinase cascade is required for p27 down regulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. Cell Physiol. 277 (1999) C652-C664
35. Salvesen G.S., and Dixit V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96 (1999) 10964-10967
36. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
37. Cdc2 activation required for apoptosis. Science 263 (1994) 1143-1145
38. Stevnsner T., and Bohr V.A. Studies on the role of topoisomerase in general, gene- and strand-specific DNA repair. Carcinogenesis 14 (1993) 1841-1850
39. Suda T., and Nagata S. Why do defects in the Fas-Fas ligand system cause autoimmunity?. J. Allergy Clin. Immunol. 100 (1997) S97-S101
40. Walker P.R., Smith C., Youdale T., Leblanc J., Whitfield J.F., and Sikorska M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51 (1991) 1078-1085
41. Wu S.J., Ng L.T., Chen C.H., Lin D.L., Wang S.S., and Lin C.C. Antihepatoma activity of PA and P. peruviana extracts and their effects on apoptosis in human Hep G2 cells. Life Sci. 74 16 (2004) 2061-2073
42. Yang R., Nakamaki T., Lubbert M., Said J., Sakashita A., Freyaldenhoven B.S., Spira S., Huynh V., Muller C., and Koeffler H.P. Cyclin A1 expression in leukemia and normal hematopoietic cells. Blood 93 (1999) 2067-2074
43. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., and Kojiro M. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G2/M phase. Cancer Res. 54 (1994) 448-454
44. Yin M., Hapke G., Guo B., Azrak R.G., Frank C., and Rustum Y.M. The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer. Oncogene 20 38 (2001) 5249-5257